z-logo
open-access-imgOpen Access
Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review
Author(s) -
Gahyun Gim,
Yeseul Kim,
Yeonggyeong Park,
Min Jeong Kim,
Myungwoo Nam,
Woojung Yang,
Samantha Duarte,
Chan Mi Jung,
Elena Vagia,
Pedro Viveiros,
Young Kwang Chae
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac095
Subject(s) - nivolumab , medicine , ipilimumab , pembrolizumab , oncology , immunotherapy , microsatellite instability , combination therapy , cancer , allele , biochemistry , chemistry , microsatellite , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom